Copenhagen, Denmark, 20 April 2023 – Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company developing novel oral therapies for retinal vascular diseases
More
Experts advise European SME packaging firms to expand or seek acquisition prior to Pharmapack Europe
2023 will see continued packaging consolidation, increased device viscosity capabilities and a more forgiving MDR runway Paris – Ahead of next
MoreBelgium team to expand under Country Manager, Dr Pierre-Hervé Brun, providing CNS treatments to patients Brussels and Düsseldorf – Neuraxpharm
More
In-person visitor numbers rebound sharply, with record C-Suite attendance and the largest ever online presence Amsterdam – The global pharma industry
More
QS-21 in blockbuster Shingles vaccine, first vaccine approved for Malaria, promising RSV phase III candidate, and Covid-19 applications. Botanical
More
Terumo Pharmaceutical Solutions (TPS), a division of Terumo Corporation (TSE: 4543) and a leading manufacturer of injection, primary container, and
More